Molecular Cancer

{{Short description|Peer-reviewed scientific journal}}

{{Infobox Journal

| title = Molecular Cancer

| cover =

| former_name =

| abbreviation = Mol. Cancer

| discipline = Biology

| language =

| editor = Chi V. Dang

| publisher = Springer Science+Business Media

| country =

| history = 2002–present

| frequency =

| openaccess =

| license =

| impact = 41.444

| impact-year = 2021

| ISSN = 1476-4598

| eISSN =

| CODEN =

| JSTOR =

| LCCN =

| OCLC =

| website = https://molecular-cancer.biomedcentral.com/

| link1 =

| link1-name =

| link2 = https://molecular-cancer.biomedcentral.com/articles

| link2-name = Online archive

| link3 =

| link3-name =

}}

Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research.

The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research.{{Cite web |title=Ludwig Cancer Research |url=https://www.ludwigcancerresearch.org/scientist/chi-van-dang/ |access-date=2023-02-19}} Professor C. Nicot has been editor-in-chief since 2014.

Molecular Cancer publishes research articles, reviews, and commentaries related to cancer biology, molecular oncology, cancer genetics, epigenetics, signal transduction, and targeted therapy.{{Cite web |title=Molecular Cancer |url=https://molecular-cancer.biomedcentral.com/ |access-date=2023-02-19 |website=BioMed Central |language=en}}